Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Six arms: Cagrilintide at doses 0.3, 0.6, 1.2, 2.4, 4.5 mg/week SC vs Liraglutide 3.0 mg/day vs placebo
60 (5): e341-4
This clinical guideline addresses the definition, diagnosis, differential diagnosis, and treatment of gastroparesis, including nutritional supplementation, glycemic control, pharmacological, endoscopic, device, and surgical therapy
Tirzepatide is a dual GIP and GLP-1 agonist that generally produces greater weight loss than semaglutide alone
US$ 20.68
US$ 24.98
US$ 27.33
US$ 26.95
US$ 24.83
US$ 20.32
US$ 27.53
US$ 27.77
